The review is part of a yearslong government effort to regulate the multibillion-dollar vaping industry
— Electronic cigarette companies will have four additional months to submit their products for government review because of delays tied to the coronavirus outbreak.
The Food and Drug Administration said Thursday that a federal court accepted its request to push back the May 12 deadline to submit vaping product applications to Sept. 9.The agency said the COVID-19 pandemic has caused delays for the companies and FDA staff. The review is part of the FDA’s yearslong effort to regulate the multibillion-dollar vaping industry, which includes thousands of e-cigarette devices and flavored solutions. E-cigarettes first appeared in the U.S. more than a decade ago and have grown in popularityAfter a surge in underage vaping, health advocacy groups successfully sued the FDA last year to speed up its review of vaping products. The court ordered the FDA to set the May 12 application deadline.
FDA Commissioner Dr. Stephen Hahn said in a statement that e-cigarette companies have reported problems completing their research because of travel restrictions and limited laboratory access. Hahn also explained that many FDA staff who would have reviewed the applications are assisting with the pandemic response.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Movies Delayed Due to Coronavirus: Find Out the New Release DatesYou'll have to wait a little longer to see 'Black Widow,' 'Wonder Woman 1984' and more.
Read more »
Photos show doctors and nurses improvising due to lack of PPE - Business InsiderPhotos show how shortages are forcing doctors and nurses to improvise coronavirus PPE from snorkel masks, pool noodles, and trash bags
Read more »
Juul, Rival E-Cigarette Makers Get More Time Before FDA Review Due to CoronavirusJuul Labs and other e-cigarette makers now have until early September to either submit their vaping products for federal review or take them off the U.S. market, after the deadline was extended from May due to the coronavirus pandemic.
Read more »